Celularity Inc.
Celularity, headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by delivering off-the-shelf allogeneic placenta-derived cellular therapies at unparalleled scale, quality and economics. Celularitys innovative approach to cell therapy harnesses the unique therapeutic potential locked within the postpartum placenta. Through natures immunotherapy engine the placenta Celularity is leading the next evolution of cellular medicine with placenta-derived T cells, NK cells, and pluripotent stem cells to target unmet and underserved clinical needs in cancer, infectious and degenerative diseases.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Globally (various continents)
- Year Founded:
- 2016
About Us
OUR MISSION
-
Unmet Global Need : Significant unmet global need for allogeneic cellular medicines delivered on-demand, off-the-shelf
-
Groundbreaking Research : Groundbreaking basic & translational research into the unique biological activity of placental-derived cells
-
Pioneering Technology : Pioneering technology platform of placental-derived cellular medicines and advanced biomaterials
-
Industry Timing : The time has arrived for cellular medicines that overcome barriers of scale, quality, and economics